Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2013  |  Volume : 9  |  Issue : 1  |  Page : 17-21

Image-guided intensity-modulated whole abdominal radiation therapy in relapsed epithelial ovarian cancers: A feasibility study

1 Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
2 Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
3 Department of Gynecologic Oncology, Tata Memorial Centre, Mumbai, India

Correspondence Address:
Umesh Mahant Shetty
Department of Radiation Oncology, Tata Memorial Centre, Dr. E. Borges Marg, Mumbai
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-1482.110343

Rights and Permissions

Background and Purpose: Advanced epithelial ovarian cancer is associated with high relapse rates. Various consolidative therapies, including whole abdominal radiationtherapy (WAR), have been tried in the past with limited success. We report here a feasibility study and clinical outcome of WAR with helical tomotherapy (HT). Materials and Methods: Eight patients with relapsed carcinoma ovary after standard treatment and deemed not suitable for further chemotherapy were treated with WAR using HT. All patients underwent intensity-modulated radiotherapy (IMRT) planning process and a dose of 25Gy/25#, at 1Gy/# to the whole of the abdomen [abdominal planning treatment volume (PTV)] with a simultaneous boost of 45Gy/25#, at 1.8Gy/# to the pelvic PTV was prescribed. Results: There was an excellent coverage in both abdominal and pelvic PTVs.The V 95% (volume covered by the 95% isodose) and V 107% (volume receiving 107% dose) was 95.6 (±2.7)% and 2.6 (±0.5)% for abdominal PTV and 95.7 (±2.4)% and 0% for pelvic PTV, respectively. With a median follow-up of 15 months (10-24 months, mean: 14 months), 3patients developed disease recurrence. All 3recurred in the peritoneum, one progressed to intestinal obstruction and fatal septicemia. Conclusion: WAR in recurrent/relapsed epithelial ovarian cancer is feasible with acceptable toxicities.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded337    
    Comments [Add]    
    Cited by others 2    

Recommend this journal